NBIX Stock Summary and Trading Ideas (Neurocrine Biosciences | NASDAQ:NBIX)

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

What symbol and exchange does Neurocrine Biosciences shares trade?

Neurocrine Biosciences trades on the NASDAQ stock market under the symbol NBIX.

What is Neurocrine Biosciences stock price doing today?

As of April 6, 2026, NBIX stock price climbed to $132.48 with 1,874,384 million shares trading.

What is Neurocrine Biosciences's Beta?

NBIX has a beta of 0.85, meaning it tends to be less sensitive to market movements. NBIX has a correlation of 0.22 to the broad based SPY ETF.

How much is Neurocrine Biosciences worth?

NBIX has a market cap of $13.30 billion. This is considered a Large Cap stock.

How much money does Neurocrine Biosciences make?

Last quarter Neurocrine Biosciences reported $806 million in Revenue and $1.88 earnings per share. This beat revenue expectation by $19 million and missed earnings estimates by -$.21.

What is the highest and lowest price Neurocrine Biosciences traded in the last 3 year period?

In the last 3 years, NBIX traded as high as $160.18 and as low as $84.23.

What are the top ETFs holding Neurocrine Biosciences?

The top ETF exchange traded funds that NBIX belongs to (by Net Assets): IJH, VTI, VB, VBK, VXF.

Is Neurocrine Biosciences (NBIX) a good investment?

NBIX has outperformed the market in the last year with a price return of +38.5% while the SPY ETF gained +31.9%. NBIX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning -3.5% and +4.3%, respectively, while the SPY returned -4.5% and +0.5%, respectively.

What are the support and resistance levels for Neurocrine Biosciences (NBIX)?

NBIX support price is $129.09 and resistance is $134.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NBIX shares will trade within this expected range on the day.